[C:1]([C:3]1([CH2:18][CH2:19][CH2:20][N:21]([CH3:23])[CH3:22])[C:9]2[CH:10]=[CH:11][CH:12]=[CH:13][C:8]=2[CH2:7][O:6][C:5]2[CH:14]=[CH:15][CH:16]=[CH:17][C:4]1=2)#[N:2].[ClH:24]>CCOCC>[ClH:24].[C:1]([C:3]1([CH2:18][CH2:19][CH2:20][N:21]([CH3:23])[CH3:22])[C:9]2[CH:10]=[CH:11][CH:12]=[CH:13][C:8]=2[CH2:7][O:6][C:5]2[CH:14]=[CH:15][CH:16]=[CH:17][C:4]1=2)#[N:2]A solution of 11-cyano-11-[3-(dimethylamino)propyl]-6,11-dihydrodibenz[b,e]oxepin of Example 4 (3.0 g; 0.009 mole) in dry ether is vigorously stirred and cooled in an ice bath. A saturated solution of HCl in ether is added dropwise until no more salt precipitates. The salt is filtered, washed with ether and dried. Two recrystallizations from methanol-ether provide 1.1 g of crystals of 11-cyano-11-[3-dimethylamino)propyl[-6,11-dihydrodibenz[b,e]oxepin hydrochloride, m.p. 219° C.
読み込み中…